Sundar PichaiSundar Pichai earned $164M in 2023
S

Doug Ingram

CEO of Sarepta Therapeutics, Inc.

Education

MBA from the Wharton School of the University of Pennsylvania

Field of Expertise

Healthcare & Life Sciences - Pharmaceuticals

Born

January 1, 1972 - 53 years ago

Economy Sector

Healthcare

Current Tenure

8 years 8 months (Jun 2016 - Present)

Previous Experience

President of the North America region at Celgene Corporation

Doug Ingram is the President and CEO of Sarepta Therapeutics, Inc., a company at the forefront of developing transformative therapies for rare diseases. He earned his MBA from the Wharton School at the University of Pennsylvania, which provides him with...

Year

2023

Total Compensation

$1.68M

Salary

$814.03K

Board Justification

The compensation program aims to attract and retain qualified executives, motivate performance, and align interests with stockholders through competitive pay and performance-based incentives.

Bonus

$842.52K

Board Justification

Performance-based cash payment based on achievement of 2023 corporate goals, resulting in 115% of target bonus.

Other

$19.02K

Board Justification

Includes matching contributions to 401(k) account and long-term disability premiums.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards were granted or vested in 2023.

Performance Metrics

Performance metrics for 2023 included product revenue goals and achieving regulatory milestones.